Comparison of Prophylactic Photobiomodulation Protocols in Chemoinduced Oral Mucositis in Oncology Patients

NARecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

March 10, 2023

Primary Completion Date

April 1, 2025

Study Completion Date

December 31, 2025

Conditions
Oral MucositisChemotherapeutic ToxicityChildhood Cancer
Interventions
DEVICE

Diode Semiconductor, Duo

Intraoral photobiomodulation therapy (660nm, 3s/point, 10J/cm²) for the management for the oral mucositis in pediatric patients. Mainly in the decrease of oral mucositis rates severity, healing of the ulcers of OM. The results obtained will be compared with the other group.

DEVICE

Gemini laser

Extraoral photobiomodulation therapy (810 + 980 nm, 20s/point, 4.07J/cm²) for the management for the oral mucositis in pediatric patients. Mainly in the decrease of oral mucositis rates severity, healing of the ulcers of OM. The results obtained will be compared with the other group.

Trial Locations (1)

90035-004

RECRUITING

Federal University of Rio Grande do Sul, Porto Alegre

All Listed Sponsors
collaborator

Hospital A.C. Camargo

OTHER

lead

Federal University of Rio Grande do Sul

OTHER